HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

VCRP operations

This article was originally published in The Rose Sheet

Executive Summary

Voluntary Cosmetics Reporting Program online beta testing will be completed by end of calendar year 2000, and the system will be running by early 2001, FDA Office of Cosmetics & Colors Acting Director Adele Dennis reports. Implementing a T3 communications line, which will increase online programming, remains a "major problem" in the initiative, she notes. Adding incentives to boost program participation will be topic of discussion during upcoming meetings between FDA and several trade associations (1"The Rose Sheet" May 1, In Brief). Separately, FDA adverse reactions 10-year report will be published in early 2001 and will be "more significant" than those issued in the past, Dennis adds

Latest Headlines
See All
UsernamePublicRestriction

Register

RS008641

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel